Home >Companies >News >Paracetamol, antibiotics, vitamins on export ban list to fight coronavirus
The outbreak of Coronavirus in China, which has killed more than 3,000 people globally, is said to be impacting the supply of several medicines in India. (Mint)
The outbreak of Coronavirus in China, which has killed more than 3,000 people globally, is said to be impacting the supply of several medicines in India. (Mint)

Paracetamol, antibiotics, vitamins on export ban list to fight coronavirus

  • Paracetamol, Vitamin B1, Vitamin B6, Vitamin B12 and their formulations are on the export ban list
  • The export ban is seen as an attempt by the government to protect the supply of essential medicines in the domestic market

NEW DELHI : As fresh cases of coronavirus are reported from India, the central government has banned the export of certain medicines including the popular Paracetamol, several antibiotics and vitamin formulations.

The export ban list includes Paracetamol, Vitamin B1, Vitamin B6, Vitamin B12 and their formulations. Export of 26 active pharmaceutical ingredients (APIs) and formulations require licence from the directorate general of foreign trade (DGFT) which has now ordered restrictions on 13 APIs.

"Export of specified APIs and formulations made from these APIs ...is hereby restricted with immediate effect and till further orders, " the DGFT said in a notification.

The 13 APIs and their formulations include paracetamol, tinidazole, metronidazole, acyclovir, vitamins B1, B6 and B12, progesterone, chloramphenicol, erythromycin and clindamycin salts, neomycin and ornidazole.

The outbreak of Coronavirus in China, which has killed more than 3,000 people globally, is said to be impacting the supply of several medicines in India.

The number of confirmed cases of the coronavirus has gone up to five so far. Three of them, all from Kerala, have been discharged while the other two patients are under treatment. The outbreak has killed more than 3,000 people globally.

Subscribe to newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperLivemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

Close
×
My Reads Logout